113 related articles for article (PubMed ID: 9050224)
1. Chiral resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin in capillary electrophoresis.
Eberle D; Hummel RP; Kuhn R
J Chromatogr A; 1997 Jan; 759(1-2):185-92. PubMed ID: 9050224
[TBL] [Abstract][Full Text] [Related]
2. Optimization and validation of a novel CE method for the enantioseparation of pantoprazole and related benzimididazole using a dual chiral selector system.
Guan J; Li H; Yan F; Shi S; Wang S
Electrophoresis; 2014 Oct; 35(19):2800-6. PubMed ID: 25082620
[TBL] [Abstract][Full Text] [Related]
3. Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography.
Ekpe A; Jacobsen T
Drug Dev Ind Pharm; 1999 Sep; 25(9):1057-65. PubMed ID: 10518247
[TBL] [Abstract][Full Text] [Related]
4. Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate.
Moustafa AA
J Pharm Biomed Anal; 2000 Feb; 22(1):45-58. PubMed ID: 10727122
[TBL] [Abstract][Full Text] [Related]
5. [Electrochemical behaviour of pantoprazole].
Knoth H
Pharmazie; 2004 Mar; 59(3):231. PubMed ID: 15074600
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats.
Masubuchi N; Yamazaki H; Tanaka M
Chirality; 1998; 10(8):747-53. PubMed ID: 9803530
[TBL] [Abstract][Full Text] [Related]
7. Stability of pantoprazole in an extemporaneously compounded oral liquid.
Dentinger PJ; Swenson CF; Anaizi NH
Am J Health Syst Pharm; 2002 May; 59(10):953-6. PubMed ID: 12040734
[No Abstract] [Full Text] [Related]
8. Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds.
Kromer W
Digestion; 1995; 56(6):443-54. PubMed ID: 8536813
[TBL] [Abstract][Full Text] [Related]
9. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations.
Wahbi AA; Abdel-Razak O; Gazy AA; Mahgoub H; Moneeb MS
J Pharm Biomed Anal; 2002 Nov; 30(4):1133-42. PubMed ID: 12408904
[TBL] [Abstract][Full Text] [Related]
10. Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole.
Dixit S; Dubey R; Bhushan R
Biomed Chromatogr; 2014 Jan; 28(1):112-9. PubMed ID: 23616104
[TBL] [Abstract][Full Text] [Related]
11. Chiral separation of ephedrine isomers by capillary electrophoresis using bovine serum albumin as a buffer additive.
Ye N; Gu X; Luo G
J Chromatogr Sci; 2007; 45(5):246-50. PubMed ID: 17555631
[TBL] [Abstract][Full Text] [Related]
12. Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates.
Salama F; El-Abasawy N; Abdel Razeq SA; Ismail MM; Fouad MM
J Pharm Biomed Anal; 2003 Oct; 33(3):411-21. PubMed ID: 14550860
[TBL] [Abstract][Full Text] [Related]
13. Square-wave adsorptive cathodic stripping voltammetry of pantoprazole.
Radi A
J Pharm Biomed Anal; 2003 Nov; 33(4):687-92. PubMed ID: 14623594
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
15. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
Röhss K; Lind T; Wilder-Smith C
Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of pantoprazole and its two metabolites in dog plasma by HPLC.
Xie Z; Chen X; Jin F; Zhong D
J Chromatogr Sci; 2005; 43(5):271-5. PubMed ID: 15975247
[TBL] [Abstract][Full Text] [Related]
17. [Studies on chiral inversion of dextropantoprazole in human].
Xie ZY; Yang BH; Zhang YF; Zhong DF
Yao Xue Xue Bao; 2004 May; 39(5):370-3. PubMed ID: 15338882
[TBL] [Abstract][Full Text] [Related]
18. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
[TBL] [Abstract][Full Text] [Related]
19. Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.
Johnson CE
Am J Health Syst Pharm; 2005 Nov; 62(22):2410-2. PubMed ID: 16278334
[No Abstract] [Full Text] [Related]
20. Conformational analysis: a new approach by means of chemometrics.
Bruni AT; Leite VB; Ferreira MM
J Comput Chem; 2002 Jan; 23(2):222-36. PubMed ID: 11926199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]